Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Short term Debt (2016 - 2026)

Phibro Animal Health has reported Short term Debt over the past 13 years, most recently at $20.6 million for Q4 2025.

  • For Q4 2025, Short term Debt rose 27.0% year-over-year to $20.6 million; the TTM value through Dec 2025 reached $20.6 million, up 27.0%, while the annual FY2025 figure was $16.2 million, 45.46% down from the prior year.
  • Short term Debt for Q4 2025 was $20.6 million at Phibro Animal Health, up from $18.4 million in the prior quarter.
  • Over five years, Short term Debt peaked at $29.8 million in Q1 2024 and troughed at $4.8 million in Q3 2021.
  • A 5-year average of $17.7 million and a median of $16.2 million in 2024 define the central range for Short term Debt.
  • Biggest five-year swings in Short term Debt: skyrocketed 1152.65% in 2021 and later plummeted 68.94% in 2024.
  • Year by year, Short term Debt stood at $13.1 million in 2021, then increased by 17.49% to $15.4 million in 2022, then skyrocketed by 68.9% to $26.0 million in 2023, then plummeted by 37.61% to $16.2 million in 2024, then rose by 27.0% to $20.6 million in 2025.
  • Business Quant data shows Short term Debt for PAHC at $20.6 million in Q4 2025, $18.4 million in Q3 2025, and $16.2 million in Q2 2025.